Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women's health by offering new choices through innovation with a particular focus on contraception and menopause. It operates through the following segments: Product Sales, Out-Licensing, and Other. The Product Sales segment includes complex therapeutics, estetrol, and the remaining portfolio of generic products. The Out-Licensing segment offers partnership deals. The Other segment is involved in the research and development services rendered to third parties. The company was founded by Jean-Michel Foidart and Fran?ois Fornieri on July 8, 1999 and is headquartered in Liege, Belgium.